Congenital disorders of glycosylation with defective fucosylation.


Journal

Journal of inherited metabolic disease
ISSN: 1573-2665
Titre abrégé: J Inherit Metab Dis
Pays: United States
ID NLM: 7910918

Informations de publication

Date de publication:
11 2021
Historique:
revised: 02 08 2021
received: 19 04 2021
accepted: 10 08 2021
pubmed: 15 8 2021
medline: 4 2 2022
entrez: 14 8 2021
Statut: ppublish

Résumé

Fucosylation is essential for intercellular and intracellular recognition, cell-cell interaction, fertilization, and inflammatory processes. Only five types of congenital disorders of glycosylation (CDG) related to an impaired fucosylation have been described to date: FUT8-CDG, FCSK-CDG, POFUT1-CDG SLC35C1-CDG, and the only recently described GFUS-CDG. This review summarizes the clinical findings of all hitherto known 25 patients affected with those defects with regard to their pathophysiology and genotype. In addition, we describe five new patients with novel variants in the SLC35C1 gene. Furthermore, we discuss the efficacy of fucose therapy approaches within the different defects.

Identifiants

pubmed: 34389986
doi: 10.1002/jimd.12426
doi:

Substances chimiques

Glycoproteins 0
Monosaccharide Transport Proteins 0
SLC35C1 protein, human 0
Fucose 28RYY2IV3F

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1441-1452

Informations de copyright

© 2021 SSIEM.

Références

Péanne R, de Lonlay P, Foulquier F, et al. Congenital disorders of glycosylation (CDG): quo vadis? Eur J Med Genet. 2018;61:643-663.
Verheijen J, Tahata S, Kozicz T, Witters P, Morava E. Therapeutic approaches in congenital disorders of glycosylation (CDG) involving N-linked glycosylation: an update. Genet Med. 2020;22:268-279.
de Mattos LC. Structural diversity and biological importance of ABO, H, Lewis and secretor histo-blood group carbohydrates. Rev Bras Hematol Hemoter. 2016;38:331-340.
Mondal N, Dykstra B, Lee J, et al. Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells. J Biol Chem. 2018;293:7300-7314.
Becker DJ, JBJG L. Fucose: biosynthesis and biological function in mammals. 2003;13:41R-53R.
Johnston DS, Wright WW, Shaper JH, Hokke CH, Van den Eijnden DH, Joziasse DH. Murine sperm-zona binding, a fucosyl residue is required for a high affinity sperm-binding ligand. A second site on sperm binds a nonfucosylated, beta-galactosyl-capped oligosaccharide. J Biol Chem. 1998;273:1888-1895.
Fenderson BA, Eddy EM, Hakomori S. Glycoconjugate expression during embryogenesis and its biological significance. Bioessays. 1990;12:173-179.
Bendahmane M, Abou-Haïla A. Characterization of glycoconjugates in the epididymal epithelium and luminal fluid during postnatal development of the mouse. Cell Tissue Res. 1997;287:611-619.
Foster DW, Ginsburg V. Biosynthesis of l-fucose by mammalian tissue. Biochim Biophys Acta. 1961;54:376-378.
Yurchenco PD, Atkinson PH. Equilibration of fucosyl glycoprotein pools in HeLa cells. Biochemistry. 1977;16:944-953.
Tonetti M, Sturla L, Bisso A, Benatti U, De Flora A. Synthesis of GDP-l-fucose by the human FX protein. J Biol Chem. 1996;271:27274-27279.
Michalski J-C, Klein A (1999) Glycoprotein lysosomal storage disorders: α-and β-mannosidosis, fucosidosis and α-N-acetylgalactosaminidase deficiency. 1455: 69-84
Ishihara H, Massaro DJ, Heath EC (1968) The metabolism of l-fucose III. The enzymatic synthesis of β-l-fucose 1-phosphate. 243: 1103-1109
Wang Y, Shao L, Shi S, et al. Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase. J Biol Chem. 2001;276:40338-40345.
Chen CI, Keusch JJ, Klein D, Hess D, Hofsteenge J, Gut H. Structure of human POFUT2: insights into thrombospondin type 1 repeat fold and O-fucosylation. EMBO J. 2012;31:3183-3197.
Schneider M, Al-Shareffi E, Haltiwanger RS. Biological functions of fucose in mammals. Glycobiology. 2017;27:601-618.
Moloney DJ, Haltiwanger RSJG (1999) The O-linked fucose glycosylation pathway: identification and characterization of a uridine diphosphoglucose: fucose-β1, 3-glucosyltransferase activity from Chinese hamster ovary cells. 9: 679-687
McKibbin JM. Fucolipids. J Lipid Res. 1978;19:131-147.
Ng BG, Rosenfeld JA, Emrick L, et al. Pathogenic variants in fucokinase cause a congenital disorder of glycosylation. Am J Hum Genet. 2018a;103:1030-1037.
Feichtinger RG, Hüllen A, Koller A et al. A spoonful of L-fucose-an efficient therapy for GFUS-CDG, a new glycosylation disorder. EMBO Mol Med. 2021;e14332. https://doi.org/10.15252/emmm.202114332
Cagdas D, Yilmaz M, Kandemir N, Tezcan I, Etzioni A, Sanal Ö. A novel mutation in leukocyte adhesion deficiency type II/CDGIIc. J Clin Immunol. 2014;34:1009-1014.
Dauber A, Ercan A, Lee J, et al. Congenital disorder of fucosylation type 2c (LADII) presenting with short stature and developmental delay with minimal adhesion defect. Hum Mol Genet. 2014;23:2880-2887.
Etzioni A, Frydman M, Pollack S, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327:1789-1792.
Etzioni A, Sturla L, Antonellis A, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 2002;110:131-135.
Frydman M, Etzioni A, Eidlitz-Markus T, et al. Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet. 1992;44:297-302.
Gazit Y, Mory A, Etzioni A, et al. Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature. J Clin Immunol. 2010;30:308-313.
Helmus Y, Denecke J, Yakubenia S, et al. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood. 2006;107:3959-3966.
Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705-1712.
Knapp KM, Luu R, Baerenfaenger M, et al. Biallelic variants in SLC35C1 as a cause of isolated short stature with intellectual disability. J Hum Genet. 2020;65:743-750.
Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Körner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73-76.
Lühn K, Wild MK, Eckhardt M, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69-72.
Marquardt T, Brune T, Lühn K, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr. 1999a;134:681-688.
Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999b;94:3976-3985.
Ng BG, Dastsooz H, Silawi M, et al. Expanding the molecular and clinical phenotypes of FUT8-CDG. J Inherit Metab Dis. 2020;43:871-879.
Ng BG, Xu G, Chandy N, et al. Biallelic mutations in FUT8 cause a congenital disorder of glycosylation with defective fucosylation. Am J Hum Genet. 2018c;102:188-195.
Koda Y, Soejima M, Johnson PH, Smart E, Kimura H. Missense mutation of FUT1 and deletion of FUT2 are responsible for Indian Bombay phenotype of ABO blood group system. Biochem Biophys Res Commun. 1997;238:21-25.
Buket Basmanav F, Fritz G, Lestringant GG, et al. Pathogenicity of POFUT1 in Dowling-Degos disease: additional mutations and clinical overlap with reticulate acropigmentation of kitamura. J Invest Dermatol. 2015;135:615-618.
Li M, Cheng R, Liang J, et al. Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease. Am J Hum Genet. 2013a;92:895-903.
Park JH, Reunert J, He M, et al. l-Fucose treatment of FUT8-CDG. Mol Genet Metab Rep. 2020;25:100680.
Lefeber DJ, Morava E, Jaeken J. How to find and diagnose a CDG due to defective N-glycosylation. J Inherit Metab Dis. 2011;34:849-852.

Auteurs

Andreas Hüllen (A)

Centre for Child and Adolescent Medicine, Department 1, University of Heidelberg, Heidelberg, Germany.

Kristina Falkenstein (K)

Centre for Child and Adolescent Medicine, Department 1, University of Heidelberg, Heidelberg, Germany.

Corina Weigel (C)

Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

Hidde Huidekoper (H)

Department of Pediatrics, Center for Lysosomal and Metabolic Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Nora Naumann-Bartsch (N)

Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

Johannes Spenger (J)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.

René G Feichtinger (RG)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.

Jacqueline Schaefers (J)

Department of Pediatrics, Center for Lysosomal and Metabolic Diseases, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Stephanie Frenz (S)

Department of Pediatrics, Dr von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

Daniel Kotlarz (D)

Department of Pediatrics, Dr von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.

Tooba Momen (T)

Department of Asthma, Allergy and Clinical Immunology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Razieh Khoshnevisan (R)

Department of Immunology, Medical Faculty, Isfahan University of Medical Sciences, Isfahan, Iran.
Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Korbinian M Riedhammer (KM)

Institute of Human Genetics, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
Department of Nephrology, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

René Santer (R)

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Theresia Herget (T)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Alexander Rennings (A)

Department of Pediatrics, Radboud Center for Mitochondrial Medicine, Amalia Children's Hospital, Nijmegen, The Netherlands.

Dirk J Lefeber (DJ)

Department of Neurology, Translational Metabolic Laboratory, Donders Center for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen, The Netherlands.

Johannes A Mayr (JA)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.

Christian Thiel (C)

Centre for Child and Adolescent Medicine, Department 1, University of Heidelberg, Heidelberg, Germany.

Saskia B Wortmann (SB)

University Children's Hospital, Salzburger Landeskliniken (SALK) and Paracelsus Medical University (PMU), Salzburg, Austria.
Department of Pediatrics, Radboud Center for Mitochondrial Medicine, Amalia Children's Hospital, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH